10-117241726-G-A
Variant summary
Our verdict is Likely pathogenic. The variant received 6 ACMG points: 6P and 0B. PVS1_StrongPM2
The NM_003054.6(SLC18A2):c.33G>A(p.Trp11*) variant causes a stop gained change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_003054.6 stop_gained
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC18A2 | NM_003054.6 | c.33G>A | p.Trp11* | stop_gained | Exon 2 of 16 | ENST00000644641.2 | NP_003045.2 | |
SLC18A2-AS1 | NR_184310.1 | n.171C>T | non_coding_transcript_exon_variant | Exon 2 of 3 | ||||
SLC18A2-AS1 | NR_184309.1 | n.113+159C>T | intron_variant | Intron 1 of 1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Brain dopamine-serotonin vesicular transport disease Pathogenic:1
- -
not provided Uncertain:1
Not observed in large population cohorts (Lek et al., 2016); Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is not a known mechanism of disease; Has not been previously published as pathogenic or benign to our knowledge -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at